skip to main content
Language:

Calling for policy actions to increase access to long-acting antipsychotics in low-income and middle-income countries

Epidemiology and psychiatric sciences, 2022-05, Vol.31, p.e34-e34, Article e34 [Peer Reviewed Journal]

Copyright © The Author(s), 2022. Published by Cambridge University Press ;Copyright © The Author(s), 2022. Published by Cambridge University Press. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 2022 The Author(s) ;ISSN: 2045-7960 ;EISSN: 2045-7979 ;DOI: 10.1017/S2045796022000166 ;PMID: 35543395

Full text available

Citations Cited by
  • Title:
    Calling for policy actions to increase access to long-acting antipsychotics in low-income and middle-income countries
  • Author: Ostuzzi, Giovanni ; Gastaldon, Chiara ; Papola, Davide ; Barbui, Corrado
  • Subjects: Antipsychotic Agents - therapeutic use ; Antipsychotics ; Developing Countries ; Drugs, Essential ; Humans ; Policy ; Psychotropic drugs ; Schizophrenia ; Schizophrenia - drug therapy
  • Is Part Of: Epidemiology and psychiatric sciences, 2022-05, Vol.31, p.e34-e34, Article e34
  • Description: Schizophrenia-spectrum disorders are associated with substantial impairment and disability. Lack of treatment adherence is a major issue, especially in low- and middle-income countries (LMICs). Despite growing evidence supporting second-generation long-acting antipsychotics (LAIs) as an effective strategy to ensure continued maintenance treatment in schizophrenia, access to these technologies has been very limited in constrained-resource settings. Including second-generation LAIs in national and international essential medicines lists and evidence-based guidelines, promoting public health-oriented patent pooling and extending their availability to primary health care settings, are key actions that should urgently be implemented to increase access to long-acting technologies. Implementing these policy actions can pragmatically improve treatment adherence, ultimately tackling schizophrenia-related impairment and disability in LMICs, which can be regarded as a global health priority.
  • Publisher: Cambridge, UK: Cambridge University Press
  • Language: English;Italian
  • Identifier: ISSN: 2045-7960
    EISSN: 2045-7979
    DOI: 10.1017/S2045796022000166
    PMID: 35543395
  • Source: ProQuest One Psychology
    Open Access: DOAJ Directory of Open Access Journals
    Open Access: PubMed Central
    Journals@Ovid Open Access Journal Collection Rolling
    MEDLINE
    ProQuest Central

Searching Remote Databases, Please Wait